nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—forebrain—narcolepsy	0.0237	0.0936	CbGeAlD
Flavoxate—PDE4C—brainstem—narcolepsy	0.0227	0.0898	CbGeAlD
Flavoxate—PDE4C—forebrain—narcolepsy	0.0219	0.0867	CbGeAlD
Flavoxate—PDE8B—midbrain—narcolepsy	0.0156	0.0618	CbGeAlD
Flavoxate—PDE8A—medulla oblongata—narcolepsy	0.0154	0.0608	CbGeAlD
Flavoxate—PDE4C—midbrain—narcolepsy	0.0145	0.0572	CbGeAlD
Flavoxate—PDE7A—brain—narcolepsy	0.0141	0.0558	CbGeAlD
Flavoxate—PDE8A—midbrain—narcolepsy	0.0141	0.0556	CbGeAlD
Flavoxate—PDE7B—brain—narcolepsy	0.0123	0.0488	CbGeAlD
Flavoxate—PDE4B—forebrain—narcolepsy	0.0102	0.0403	CbGeAlD
Flavoxate—CHRM2—forebrain—narcolepsy	0.0101	0.04	CbGeAlD
Flavoxate—PDE8B—brain—narcolepsy	0.00982	0.0388	CbGeAlD
Flavoxate—CHRM1—forebrain—narcolepsy	0.00921	0.0364	CbGeAlD
Flavoxate—PDE4C—brain—narcolepsy	0.0091	0.036	CbGeAlD
Flavoxate—PDE8A—brain—narcolepsy	0.00884	0.0349	CbGeAlD
Flavoxate—PDE4D—brain—narcolepsy	0.00801	0.0317	CbGeAlD
Flavoxate—PDE4B—medulla oblongata—narcolepsy	0.00736	0.0291	CbGeAlD
Flavoxate—PDE4A—brain—narcolepsy	0.00709	0.028	CbGeAlD
Flavoxate—PDE4B—midbrain—narcolepsy	0.00672	0.0266	CbGeAlD
Flavoxate—PDE4B—brain—narcolepsy	0.00422	0.0167	CbGeAlD
Flavoxate—CHRM2—brain—narcolepsy	0.0042	0.0166	CbGeAlD
Flavoxate—CHRM1—brain—narcolepsy	0.00382	0.0151	CbGeAlD
Flavoxate—PDE8A—Signaling Pathways—PENK—narcolepsy	0.0017	0.00228	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PENK—narcolepsy	0.0017	0.00228	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HCRT—narcolepsy	0.0017	0.00228	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—P2RY11—narcolepsy	0.0017	0.00228	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00169	0.00226	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HCRT—narcolepsy	0.00168	0.00224	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HCRTR2—narcolepsy	0.00163	0.00218	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HCRTR1—narcolepsy	0.00163	0.00218	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00163	0.00218	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—NPS—narcolepsy	0.00163	0.00218	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—TAC1—narcolepsy	0.00163	0.00218	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HCRT—narcolepsy	0.00159	0.00213	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—NPS—narcolepsy	0.00159	0.00213	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—TAC1—narcolepsy	0.00159	0.00213	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HCRT—narcolepsy	0.00158	0.00212	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—P2RY11—narcolepsy	0.00158	0.00211	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PENK—narcolepsy	0.00156	0.00209	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HCRT—narcolepsy	0.00152	0.00204	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PENK—narcolepsy	0.00152	0.00203	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00151	0.00202	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PENK—narcolepsy	0.00149	0.002	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—NPS—narcolepsy	0.00148	0.00198	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—TAC1—narcolepsy	0.00148	0.00198	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HCRT—narcolepsy	0.00148	0.00198	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00147	0.00197	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TRH—narcolepsy	0.00146	0.00195	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00145	0.00195	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TRH—narcolepsy	0.00145	0.00194	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TRH—narcolepsy	0.00145	0.00194	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HCRT—narcolepsy	0.00145	0.00194	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PENK—narcolepsy	0.00142	0.0019	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PENK—narcolepsy	0.00141	0.00189	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0014	0.00187	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00137	0.00183	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00137	0.00183	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PENK—narcolepsy	0.00136	0.00182	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00135	0.0018	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00135	0.0018	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HCRT—narcolepsy	0.00134	0.00179	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TRH—narcolepsy	0.00132	0.00177	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00132	0.00177	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PENK—narcolepsy	0.00132	0.00176	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00131	0.00176	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.0013	0.00174	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0013	0.00173	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00129	0.00173	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TRH—narcolepsy	0.00129	0.00173	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PENK—narcolepsy	0.00129	0.00173	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—HRH3—narcolepsy	0.00128	0.00171	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HRH3—narcolepsy	0.00127	0.0017	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HRH3—narcolepsy	0.00127	0.0017	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TRH—narcolepsy	0.00127	0.0017	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HCRTR1—narcolepsy	0.00126	0.00168	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HCRTR2—narcolepsy	0.00126	0.00168	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00122	0.00164	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00122	0.00164	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00122	0.00163	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—P2RY11—narcolepsy	0.00121	0.00163	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TRH—narcolepsy	0.00121	0.00162	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TRH—narcolepsy	0.0012	0.00161	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PENK—narcolepsy	0.00119	0.0016	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—HTR2A—narcolepsy	0.00118	0.00158	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—HTR2A—narcolepsy	0.00118	0.00158	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HRH3—narcolepsy	0.00116	0.00155	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00116	0.00155	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TRH—narcolepsy	0.00115	0.00154	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00114	0.00153	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HRH3—narcolepsy	0.00113	0.00152	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00113	0.00151	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00112	0.0015	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TRH—narcolepsy	0.00112	0.0015	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00112	0.00149	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HRH3—narcolepsy	0.00111	0.00149	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00111	0.00148	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0011	0.00147	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TRH—narcolepsy	0.0011	0.00147	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0011	0.00147	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0011	0.00147	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HCRTR2—narcolepsy	0.00109	0.00147	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HCRTR1—narcolepsy	0.00109	0.00147	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—HTR2A—narcolepsy	0.00107	0.00144	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—HTR2A—narcolepsy	0.00107	0.00144	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—TAC1—narcolepsy	0.00106	0.00142	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—NPS—narcolepsy	0.00106	0.00142	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HRH3—narcolepsy	0.00106	0.00142	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—P2RY11—narcolepsy	0.00106	0.00141	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TAC1—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NPS—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TAC1—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NPS—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HRH3—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—HTR2A—narcolepsy	0.00105	0.00141	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HCRTR2—narcolepsy	0.00104	0.00139	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HCRTR1—narcolepsy	0.00104	0.00139	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HCRT—narcolepsy	0.00103	0.00138	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TRH—narcolepsy	0.00102	0.00136	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HRH3—narcolepsy	0.00101	0.00135	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—P2RY11—narcolepsy	0.00101	0.00135	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.001	0.00134	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.000987	0.00132	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HRH3—narcolepsy	0.000981	0.00131	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000979	0.00131	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—HTR2A—narcolepsy	0.000978	0.00131	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000966	0.00129	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HCRTR2—narcolepsy	0.000964	0.00129	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HCRTR1—narcolepsy	0.000964	0.00129	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—TAC1—narcolepsy	0.000962	0.00129	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—NPS—narcolepsy	0.000962	0.00129	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRH3—narcolepsy	0.000962	0.00129	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—HTR2A—narcolepsy	0.000956	0.00128	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TAC1—narcolepsy	0.000938	0.00126	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NPS—narcolepsy	0.000938	0.00126	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—P2RY11—narcolepsy	0.000931	0.00125	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—NPS—narcolepsy	0.000923	0.00123	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—TAC1—narcolepsy	0.000923	0.00123	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PENK—narcolepsy	0.00092	0.00123	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HCRT—narcolepsy	0.000899	0.0012	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRH3—narcolepsy	0.00089	0.00119	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—HTR2A—narcolepsy	0.000888	0.00119	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—NPS—narcolepsy	0.000878	0.00118	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—TAC1—narcolepsy	0.000878	0.00118	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NPS—narcolepsy	0.000872	0.00117	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TAC1—narcolepsy	0.000872	0.00117	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HCRT—narcolepsy	0.000856	0.00115	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00085	0.00114	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000841	0.00113	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.000839	0.00112	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—TAC1—narcolepsy	0.000838	0.00112	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—NPS—narcolepsy	0.000838	0.00112	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—TAC1—narcolepsy	0.000813	0.00109	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—NPS—narcolepsy	0.000813	0.00109	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000811	0.00109	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000811	0.00109	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PENK—narcolepsy	0.000801	0.00107	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000801	0.00107	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000801	0.00107	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—NPS—narcolepsy	0.000797	0.00107	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—TAC1—narcolepsy	0.000797	0.00107	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HCRT—narcolepsy	0.000792	0.00106	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TRH—narcolepsy	0.000782	0.00105	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000772	0.00103	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000772	0.00103	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PENK—narcolepsy	0.000763	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000762	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000762	0.00102	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.000745	0.000998	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.000745	0.000998	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—TAC1—narcolepsy	0.000738	0.000988	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—NPS—narcolepsy	0.000738	0.000988	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000737	0.000986	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.000736	0.000985	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.000736	0.000985	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PENK—narcolepsy	0.000706	0.000944	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000701	0.000938	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000701	0.000938	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.000692	0.000926	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.000692	0.000926	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRH3—narcolepsy	0.000686	0.000918	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TRH—narcolepsy	0.000681	0.000912	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.000677	0.000906	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.000668	0.000894	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000659	0.000882	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TRH—narcolepsy	0.000648	0.000868	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—HTR2A—narcolepsy	0.000638	0.000853	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.000634	0.000848	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HTR2A—narcolepsy	0.000633	0.000848	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HTR2A—narcolepsy	0.000633	0.000848	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.000626	0.000837	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.000618	0.000827	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.000618	0.000827	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00061	0.000816	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00061	0.000816	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TRH—narcolepsy	0.0006	0.000803	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRH3—narcolepsy	0.000597	0.0008	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HTR2A—narcolepsy	0.000579	0.000775	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.000576	0.00077	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000569	0.000762	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRH3—narcolepsy	0.000569	0.000761	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NPS—narcolepsy	0.000569	0.000761	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TAC1—narcolepsy	0.000569	0.000761	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.000568	0.00076	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000565	0.000756	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HTR2A—narcolepsy	0.000565	0.000756	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000562	0.000752	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.000558	0.000746	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HTR2A—narcolepsy	0.000555	0.000743	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HTR2A—narcolepsy	0.000528	0.000707	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRH3—narcolepsy	0.000526	0.000704	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HTR2A—narcolepsy	0.000525	0.000703	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.000513	0.000687	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.000506	0.000678	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HTR2A—narcolepsy	0.000504	0.000675	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NPS—narcolepsy	0.000495	0.000663	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TAC1—narcolepsy	0.000495	0.000663	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HTR2A—narcolepsy	0.000489	0.000654	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000488	0.000653	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000482	0.000645	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00048	0.000643	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HTR2A—narcolepsy	0.00048	0.000642	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.000474	0.000635	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NPS—narcolepsy	0.000471	0.000631	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TAC1—narcolepsy	0.000471	0.000631	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HTR2A—narcolepsy	0.000444	0.000594	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000436	0.000584	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TAC1—narcolepsy	0.000436	0.000583	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NPS—narcolepsy	0.000436	0.000583	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000431	0.000576	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000421	0.000564	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000416	0.000557	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000414	0.000554	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000414	0.000554	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000409	0.000547	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000409	0.000547	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.0004	0.000535	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000395	0.000528	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000382	0.000512	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000378	0.000505	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000372	0.000497	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000367	0.000491	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000362	0.000484	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000349	0.000467	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000349	0.000467	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000344	0.000461	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000344	0.000461	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR2A—narcolepsy	0.000342	0.000458	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00034	0.000455	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000336	0.000449	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000317	0.000424	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000317	0.000424	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000313	0.000419	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000313	0.000419	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000303	0.000406	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000299	0.0004	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2A—narcolepsy	0.000298	0.000399	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2A—narcolepsy	0.000283	0.000379	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2A—narcolepsy	0.000262	0.000351	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000258	0.000345	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000254	0.00034	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000226	0.000302	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000223	0.000299	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.00021	0.000281	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000207	0.000277	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000191	0.000255	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000188	0.000252	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000187	0.000251	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000187	0.000251	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000185	0.000247	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000185	0.000247	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000113	0.000151	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000111	0.000149	CbGpPWpGaD
